RET receptor tyrosine kinase architecture, assemblies, and activation. [PDF]
Zol-Hanlon M, McDonald NQ.
europepmc +1 more source
Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance? [PDF]
Omar MM, Alanazi MA, Jackson DE.
europepmc +1 more source
Mutation type, tyrosine kinase function in normal cell and tyrosine kinase inhibitor activity in cancers. [PDF]
Vanacker H +11 more
europepmc +1 more source
Non-receptor tyrosine kinase signaling pathways and therapeutic implications. [PDF]
Hossain MDA +4 more
europepmc +1 more source
Visualization of a Bruton's Tyrosine Kinase Inhibitor Using Fluorescence and Raman Microscopy. [PDF]
Merchant AS +3 more
europepmc +1 more source
Inhibition of purine nucleoside and nucleobase transporters by tyrosine kinase inhibitors. [PDF]
Shahid N +5 more
europepmc +1 more source
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. [PDF]
Fearon AE +18 more
europepmc +1 more source
Control of Schwann Cell Myelination by DDR1 Receptor Tyrosine Kinase. [PDF]
Fan M +6 more
europepmc +1 more source
Intersection of Tyrosine Kinase Inhibition and Sepsis-Induced Cardiomyopathy. [PDF]
Abe H +6 more
europepmc +1 more source
Invasive fungal infections after Bruton tyrosine kinase inhibitor treatment: a systematic review and meta-analysis. [PDF]
Srisurapanont K +10 more
europepmc +1 more source

